Prostate Cancer Research Inc.

Fiscal year ending 2023. Filed on November 7, 2024.

8 The Green Suite 8450
Dover, Delaware 19901

Prostate Cancer Research Inc. (EIN: 85-3336070) has filed an IRS Form 990 between fiscal years 2021 and 2023. In its fiscal year 2023 IRS Form 990 filing, Prostate Cancer Research Inc., a 501(c)(3) charitable organization, reported compensation for 3 out of 3 total employees. Among the employees shown here, the average compensation is $0.

Revenue, expenses, and employee compensation

Revenue

$22,687

Expenses

$420,739

Employee compensation

$126,397
Revenue, expenses, and employee compensation over time

Mission Statement

THE ORGANIZATION'S HAS 6 CORE GOALS TO GUIDE THEIR DECISION MAKING. THE FIRST GOAL IS TO BECOME THE GOLD STANDARD FOR PROSTATE CANCER RESEARCH. GOAL 2 IS TO STRENGTHEN THEIR CREDIBILITY AND REPUTATION AMONG THE RESEARCH COMMUNITY. GOAL 3 IS TO FORM PARTNERSHIPS AND BUILD BRIDGES BETWEEN THE SCIENTIFIC COMMUNITY, GOVERNMENT, THE PHARMACEUTICAL INDUSTRY & THOSE AFFECTED BY PROSTATE CANCER. GOAL 4 IS TO ASSEMBLE EXPERTS ON ALL ASPECTS OF RUNNING A SUCCESSFUL AND ROBUST RESEARCH CHARITY. GOAL 5 IS TO FOSTER A CULTURE OF CONTINUOUS LEARNING, AND BUILD A SHARED SENSE OF PURPOSE TO ACHIEVE THEIR GOALS. GOAL 6 IS TO CREATE SUSTAINABLE GROWTH BY TAKING A DUAL APPROACH OF BIDDING FOR LARGER GRANTS, WHILE ALSO STRATEGICALLY INVESTING FUNDS TO BUILD FLEXIBLE FUNDING.

Revisions to this organization profile

November 7, 2024:
2023 Prostate Cancer Research Inc. 990 filed
August 22, 2023:
2022 Prostate Cancer Research Inc. 990 filed
May 10, 2022:
2021 Prostate Cancer Research Inc. 990 filed

Get an email when new compensation information is released for Prostate Cancer Research Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

Powered by Talroo